Avinger, which sells an image-guided, catheter-based system to treat peripheral arterial disease, raised $65 million by offering 5 million shares (upsized from 4.6 million shares) at $13, the midpoint of the $12 to $14. Avinger plans to list on the NASDAQ under the symbol AVGR. Avinger initially filed confidentially on 11/6/2014. Canaccord Genuity and Cowen & Company acted as lead managers on the deal.
